“…Similar to the fracture literature, the presence of a T1D-related complication including retinopathy, nephropathy, or other microvascular disease has emerged as a predictor of skeletal deficits in several studies [24, 47•, 49, 59•]. The reported effect of glycemic control on bone outcomes, however, has varied widely, with a negative association seen in some studies [28, 30, 35, 37, 41, 60] but not others [14, 23, 29, 32, 33, 39, 40]. Better glycemic control has been shown to be associated with reduced risk of other T1D-related complications in clinical trials and long-term follow-up studies [22, 61]; so, it is unclear why hyperglycemia has not emerged as a consistent predictor of skeletal deficits.…”